Schedule 13G ownership disclosure
MABVAX THERAPEUTICS HOLDINGS, INC.
Security class unavailable · CUSIP: 55414P504
Event date: 2017-09-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.6400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001654954-17-008551
- Form type
- SC 13G
- Filer
- MABVAX THERAPEUTICS HOLDINGS, INC.
- CIK
- CIK 1109196
- Filed
- Sep 19, 2017
- Reporting period
- Sep 11, 2017
- Description
- Schedule 13G beneficial ownership